Category Press Releases

Medisca and dsm–firmenich Collaborate to Broaden U.S. Access to Pharmaceutical-Grade Vitamin APIs

Medisca and dsm–firmenich Collaborate to Broaden U.S. Access to Pharmaceutical-Grade Vitamin APIs for Compounding Pharmacies Medisca, a global provider of personalized pharmaceutical solutions and compounding technologies, has announced a strategic partnership with dsm–firmenich, an international manufacturer of pharmaceutical ingredients and…

Read MoreMedisca and dsm–firmenich Collaborate to Broaden U.S. Access to Pharmaceutical-Grade Vitamin APIs

Vetter Begins Construction of New Manufacturing Facility in Germany

Vetter Begins Building New Manufacturing Facility in Germany Vetter, a globally recognized Contract Development and Manufacturing Organization specializing in aseptic filling and pharmaceutical manufacturing services, has officially launched construction activities for its newest production facility in Saarlouis, Germany. The milestone…

Read MoreVetter Begins Construction of New Manufacturing Facility in Germany

Johnson & Johnson Launches Generation Fine Campaign Focused on Depression Remission

Johnson & Johnson Launches “Generation Fine” Campaign to Encourage Better Conversations Around Depression Care and Remission Johnson & Johnson has launched Generation Fine, a new global awareness campaign focused on reshaping conversations around depression treatment and encouraging people living with…

Read MoreJohnson & Johnson Launches Generation Fine Campaign Focused on Depression Remission

Rapid Medical’s TIGERTRIEVER 13 Shows Encouraging 90-Day Results in DISTALS Trial, Supporting Key Safety and Efficacy Data

Rapid Medical Reports Positive DISTALS Trial Results for TIGERTRIEVER 13 in Distal Stroke Treatment Rapid Medical, a medical technology company focused on advanced stroke treatment solutions, has announced full results from the DISTALS randomized clinical trial during the 11th European…

Read MoreRapid Medical’s TIGERTRIEVER 13 Shows Encouraging 90-Day Results in DISTALS Trial, Supporting Key Safety and Efficacy Data

Viridian Therapeutics Plans Concurrent Offerings of Notes, Common Stock, and Preferred Shares

Viridian Therapeutics Plans Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Shares, and Series B Non-Voting Convertible Preferred Stock Viridian Therapeutics (Nasdaq: VRDN), a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and rare diseases, has…

Read MoreViridian Therapeutics Plans Concurrent Offerings of Notes, Common Stock, and Preferred Shares

RestorixHealth Marks Hyperbaric Awareness Month with Nationwide Celebration

RestorixHealth Marks Hyperbaric Awareness Month with Nationwide Celebration RestorixHealth, a leading provider of wound care and hyperbaric center management services across the United States, has announced its participation in recognizing Hyperbaric Awareness Month this May. The annual observance, launched in…

Read MoreRestorixHealth Marks Hyperbaric Awareness Month with Nationwide Celebration

Triton Robotic Endoscopy Achieves 100% Cecal Intubation with No Adverse Events in First-in-Human Study

First-in-Human Study of 50 Patients Shows Neptune Medical’s Triton Robotic Endoscopy System Achieves Zero Adverse Events and 100% Cecal Intubation in Colonoscopy Neptune Medical has reported encouraging results from its first-in-human clinical evaluation of the Triton Robotic Endoscopy System, marking…

Read MoreTriton Robotic Endoscopy Achieves 100% Cecal Intubation with No Adverse Events in First-in-Human Study

Alnylam Pharmaceuticals to Showcase New Analyses at Heart Failure 2026 Highlighting Consistent Clinical Profile of Vutrisiran in ATTR-CM

Alnylam Pharmaceuticals to Showcase New Analyses at Heart Failure 2026 Highlighting the Consistent Clinical Profile of Vutrisiran in ATTR-CM Alnylam Pharmaceuticals (Nasdaq: ALNY) has announced that it will present a comprehensive set of new data analyses for vutrisiran in patients…

Read MoreAlnylam Pharmaceuticals to Showcase New Analyses at Heart Failure 2026 Highlighting Consistent Clinical Profile of Vutrisiran in ATTR-CM

Rejoni Names MedTech Veteran John Nealon as Chief Executive Officer to Lead Women’s Health Innovation

Rejoni Names John Nealon as Chief Executive Officer to Lead Its Women’s Health MedTech Strategy Rejoni Inc., a privately held clinical-stage biotechnology company focused on advancing uterine health through innovative biomaterial therapies, has announced the appointment of John Nealon as…

Read MoreRejoni Names MedTech Veteran John Nealon as Chief Executive Officer to Lead Women’s Health Innovation

Ironwood Survey at DDW 2026 Highlights Need for Better Therapies to Reduce TPN Burden in SBS

Ironwood Presents Survey Data at DDW 2026 Highlighting Urgent Need for Treatments Addressing the Multifaceted Burden of Total Parenteral Nutrition in Short Bowel Syndrome Ironwood Pharmaceuticals, a biotechnology company focused on developing and commercializing therapies for gastrointestinal (GI) and rare…

Read MoreIronwood Survey at DDW 2026 Highlights Need for Better Therapies to Reduce TPN Burden in SBS